ALKS
AlkermesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
ALKS vs peer average
45/100
ALKS vs. peer average (C vs. C)
Grade spread
A 1 · B 4 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
IONS is the first available peer comparator.
A similarly sized commercial-stage biopharma with a neurology pipeline, but different indications and drug technology; useful for development-risk context rather than a direct product multiple. [Ionis company release](https://ir.ionis.com/news-releases/news-release-details/ionis-reports-first-quarter-2026-financial-results-and)
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALKS
Alkermes
IONS
Ionis
Grade
C
B
Momentum
55
16
Value
60
41
Sentiment
51
80
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs IONS
ALKS / IONS
Grade Position
In line
ALKS vs. peer average (C vs. C)
45/100
Momentum
55
ALKSValue
60
ALKSSentiment
51
IONSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALKS
IONS is the first peer returned for this comparison set.